Table 3.

Predictive value of six prognostic scoring systems in ACLF patients.

	28-day				90-day
	auROC	95% CI	Z value	p value	auROC	95% CI	Z value	p value
All ACLF patients
COSSH ACLFs	0.778	0.706–0.839			0.792	0.721–0.851
CLIF-C ACLFs	0.754	0.680–0.818	0.891	0.373	0.765	0.692–0.828	0.983	0.326
CLIF-SOFA	0.765	0.692–0.828	0.479	0.632	0.778	0.706–0.839	0.518	0.604
MELD	0.605	0.525–0.680	3.676	<0.001	0.602	0.523–0.678	4.088	<0.001
MELD-Na	0.620	0.541–0.695	3.474	<0.001	0.616	0.537–0.691	3.926	<0.001
iMELD	0.761	0.688–0.824	0.521	0.602	0.766	0.693–0.828	0.803	0.422
ACLF patients with cirrhosis
COSSH ACLFs	0.726	0.669–0.779			0.767	0.712–0.816
CLIF-C ACLFs	0.757	0.701–0.807	1.304	0.192	0.796	0.743–0.843	1.213	0.225
CLIF-SOFA	0.740	0.683–0.791	0.550	0.582	0.787	0.733–0.834	0.782	0.434
MELD	0.612	0.551–0.671	2.878	0.004	0.581	0.520–0.641	4.659	<0.001
MELD-Na	0.624	0.563–0.682	2.545	0.011	0.590	0.528–0.649	4.357	<0.001
iMELD	0.753	0.697–0.803	0.881	0.378	0.748	0.692–0.799	0.619	0.536
ACLF patients without cirrhosis
COSSH ACLFs	0.778	0.706–0.839			0.792	0.721–0.851
CLIF-C ACLFs	0.754	0.680–0.818	0.891	0.373	0.765	0.692–0.828	0.983	0.326
CLIF-SOFA	0.765	0.692–0.828	0.479	0.632	0.778	0.706–0.839	0.518	0.604
MELD	0.605	0.525–0.680	3.676	<0.001	0.602	0.523–0.678	4.088	<0.001
MELD-Na	0.620	0.541–0.695	3.474	<0.001	0.616	0.537–0.691	3.926	<0.001
iMELD	0.761	0.688–0.824	0.521	0.602	0.766	0.693–0.828	0.803	0.422

Data were compared by Z test (Delong’s method)